Ian Peikon

Founder at Cajal Neuroscience, Inc.

Health Technology

Consumer Services

Finance

Profile

Ian Peikon is the founder of Cajal Neuroscience, Inc. which was founded in 2020, where he holds the title of Chief Scientific Officer.
He is currently a Venture Partner at Lux Capital Group LLC since 2019 and a Board Member at Plexium, Inc. since 2022.
Dr. Peikon's former job was as Director-Platform Biology & Technology at Kallyope, Inc. from 2015 to 2019.
He received his undergraduate degree from Duke University in 2009.

Ian Peikon active positions

Companies	Position	Start
Lux Capital Group LLC Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California.	Consultant / Advisor	-
Cajal Neuroscience, Inc. Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery.	Founder	31/03/2020
Plexium, Inc. Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA.	Director/Board Member	31/07/2022

All active positions of Ian Peikon

Former positions of Ian Peikon

Companies	Position	End
Kallyope, Inc. Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY.	Corporate Officer/Principal	30/09/2019

See the detail of Ian Peikon's experience

Training of Ian Peikon

Duke University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ian Peikon's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Lux Capital Group LLC Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California.	Finance
Kallyope, Inc. Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY.	Health Services
Plexium, Inc. Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA.	Health Technology
Cajal Neuroscience, Inc. Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery.	Health Technology

See company connections